Jounce Therapeutics, Inc. (JNCE) is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial.
The Business Development Director will drive Jounce’s business development activities, support the BD strategy, and alliance management functions. In this newly created position you will play a key role in leading a range of business development transactional activities at Jounce. This highly visible position reports to the Chief Business Officer. If you thrive in a fast-paced, high science culture, this is an outstanding opportunity for you
To apply, please visit our website at https://careers-jouncetx.icims.com